Prevalence of low HDL cholesterol, and relationship between serum HDL and cardiovascular disease in elderly Spanish population: The PREV-ICTUS study

International Journal of Clinical Practice

Volumn 63, Issue 1, 2009, Pages 71-81

  Cea Calvo, L ^b   Lozano, J V ^c   Fernandez Perez C ^d   Llisterri, J L ^e   Marti Canales J C ^f   Aznar, J ^g   Gil Guillen V ^h   Redon J ^a,i  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Medical affairs Merck sharp and Dohme ltd   (Spain)

^c Serreria 2 Health Center   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e Ingeniero Joaquin Benlloch Health Center   (Spain)

^f San Antonio Health Center   (Spain)

^g HOSPITAL MARINA ALTA   (Spain)

^h MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

ⁱ HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; THORAX PAIN;

AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SPAIN;

EID: 57649231819     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01902.x     Document Type: Article

References (36)

1. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005 352 : 1685 95.
2. Kannel WB, Neaton JD, Wentworth D et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT (Multiple Risk Factor Intervention Trial). Am Heart J 1986 112 : 825 36.
3. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986 256 : 2835 8.
4. Abbott RD, Wilson PW, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction: the Framingham Study. Atherosclerosis 1988 8 : 207 11.
5. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007 28 : 2375 414.
6. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994 344 : 1383 9.
7. Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med 1995 333 : 1301 7.
8. Downs JR, Clearfield M, Weis S et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS (Air Force/Texas Coronary Atherosclerosis Prevention Study). JAMA 1998 279 : 1615 22.
9. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002 360 : 7 22.
10. Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996 124 (Suppl. S11 20.
11. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977 62 : 707 14.
12. Gordon DJ, Probstfield JL, Garrison RJ et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989 79 : 8 15.
13. Shah PK, Kaul S, Nilsson J, Cercek B. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part I. Circulation 2001 104 : 2376 83.
14. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res 2004 95 : 764 72.
15. Mineo C, Deguchi H, Griffin JH, Shaul PW. Endothelial and antithrombotic actions of HDL. Circ Res 2006 98 : 1352 64.
16. Bruckert E, Baccara-Dinet M, McCoy F, Chapman J. High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients. Curr Med Res Opin 2005 21 : 1927 34.
17. Farnier M, Garnier P, Yau C, Dejager S, Verpilleux MP. Prevalence of low HDL-cholesterol in patients with cardiovascular risk factors: The ECHOS (Etude du Cholesterol HDL en Observationnel) French Survey. Int J Clin Pract 2006 60 : 1166 71.
18. Patel JV, Kirby M, Hughes EA. The lipid audit: analysis of lipid management in two centres in Britain 2003. Br J Cardiol 2004 11 : 214 7.
19. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004 27 : 2444 9.
20. Bruckert E. Epidemiology of low HDL-cholesterol: results of studies and surveys. Eur Heart J Suppl 2006 8 : F17 22.
21. Redon J, Cea-Calvo L, Lozano JV et al. Blood pressure and estimated risk of stroke in the elderly population of Spain: The PREV-ICTUS Study. Stroke 2007 38 : 1167 73.
22. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003 139 : 137 47.
23. European Society of Hypertension. European Society of Cardiology guidelines for management of arterial hypertension. J Hypertens 2003 21 : 1011 53.
24. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation 1987 75 : 565 72.
25. Sokolow M, Lyon T. Ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949 37 : 161 86.
26. Instituto Nacional de Estadística de España (Nacional Institute of Statistics of Spain). Cifras de Población. http://www.ine.es/inebase/cgi/um?M=%2Ft20%2Fe260&O=inebase&N=&L = (accessed July 2005).
27. Andreoli A, Lauro S, Di Daniele N, Sorge R, Celi M, Volpe SL. Effect of a moderately hypoenergetic Mediterranean diet and exercise program on body cell mass and cardiovascular risk factors in obese women. Eur J Clin Nutr 2008 62 : 892 7.
28. Estruch R, Martínez-González MA, Corella D et al. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006 145 : 1 11.
29. Cea-Calvo L, Redón J, Martí-Canales JC et al. Prevalence of low glomerular filtration rate in the elderly population of Spain. The PREV-ICTUS study [Article in Spanish]. Med Clin (Barc) 2007 129 : 681 7.
30. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997 17 : 1114 20.
31. Barter P, Gotto AM, LaRosa JC et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007 357 : 1301 10.
32. Weverling-Rijnsburger AW, Jonkers IJ, Van Exel E et al. High-density vs. low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age. Arch Intern Med 2003 163 : 1549 54.
33. Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE, Clinicaltrials.gov, NCT00461630. http://www.clinicaltrials.gov/ct/show/ NCT00461630?order=1 (accessed April 2008).
34. Niacin Plus Statin to Prevent Vascular Events. Clinicaltrials.gov NCT 00120289. http://www.clinicaltrials.gov/ct2/show/NCT00120289?term=aim- high&rank=1 (accessed August 2008).
35. Gutierrez-Fisac JL, Lopez E, Banegas JR, Graciani A, Rodriguez-Artalejo F. Prevalence of overweight and obesity in elderly people in Spain. Obes Res 2004 12 : 710 5.
36. Banegas JR, Rodriguez-Artalejo F, Ruilope LM et al. Hypertension magnitude and management in the elderly population of Spain. J Hypertens 2002 20 : 2157 64.